Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect

BACKGROUND: Hypertensive left ventricular hypertrophy is associated with the risk of heart failure, coronary heart disease and cerebrovascular disease. Although sacubitril/valsartan (SAC/VAL), a first-in-class angiotensin receptor neprilysin inhibitor, reduces the risks of death and hospitalization...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashiro, Kohei, Kuwano, Takashi, Ideishi, Akihito, Morita, Hidetaka, Idemoto, Yoshiaki, Goto, Masaki, Suematsu, Yasunori, Miura, Shin-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666593/
https://www.ncbi.nlm.nih.gov/pubmed/33224383
http://dx.doi.org/10.14740/cr1137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666593/
https://www.ncbi.nlm.nih.gov/pubmed/33224383
http://dx.doi.org/10.14740/cr1137

Ejemplares similares